STOCK TITAN

GRAIL (GRAL) CFO discloses 25,000-share insider stock sale near $99

Filing Impact
(High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

GRAIL, Inc.'s Chief Financial Officer reported an insider sale of company stock. On 12/03/2025, the reporting person sold 25,000 shares of GRAIL common stock in an open market transaction coded "S" (sale). The weighted average sale price was $99.1527 per share, with individual trades executed between $99.00 and $99.76.

After this transaction, the reporting person beneficially owned 259,077 shares of GRAIL common stock, held directly. The footnote explains that the reported price is an average across multiple trades and that detailed trade-level pricing information within the stated range is available upon request.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Freidin Aaron

(Last) (First) (Middle)
C/O GRAIL, INC.
1525 O'BRIEN DRIVE

(Street)
MENLO PARK CA 94025

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
GRAIL, Inc. [ GRAL ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Financial Officer
3. Date of Earliest Transaction (Month/Day/Year)
12/03/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 12/03/2025 S 25,000 D $99.1527(1) 259,077 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $99.00 to $99.76 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate sales price within the range set forth in this footnote.
Remarks:
/s/Abram Barth, as Attorney-in-Fact for Aaron Freidin 12/05/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did GRAIL (GRAL) report in this Form 4?

The filing reports that the Chief Financial Officer sold 25,000 shares of GRAIL, Inc. common stock on 12/03/2025 in a transaction coded as a sale.

At what price were the GRAIL (GRAL) shares sold in this insider trade?

The shares were sold at a weighted average price of $99.1527 per share, with individual sale prices ranging from $99.00 to $99.76.

How many GRAIL (GRAL) shares does the insider own after this transaction?

Following the reported sale, the reporting person beneficially owned 259,077 shares of GRAIL, Inc. common stock, held directly.

Who is the insider involved in this GRAIL (GRAL) Form 4 filing and what is their role?

The insider is an officer of GRAIL, Inc., serving as Chief Financial Officer, as indicated by the relationship section of the filing.

Was the GRAIL (GRAL) insider sale executed in multiple trades?

Yes. The footnote states that the 25,000 shares were sold in multiple transactions at prices ranging from $99.00 to $99.76, resulting in the reported weighted average price.

Can investors obtain detailed pricing for each GRAIL (GRAL) trade in this Form 4?

Yes. The reporting person undertakes to provide, upon request, full information on the number of shares sold at each separate sales price within the disclosed range.
Grail Inc

NASDAQ:GRAL

GRAL Rankings

GRAL Latest News

GRAL Latest SEC Filings

GRAL Stock Data

3.44B
35.08M
13.81%
73.53%
13.42%
Diagnostics & Research
Services-medical Laboratories
Link
United States
MENLO PARK